<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2015-06-18</publicationDate>
    
        <volume>8</volume>
        <issue>1</issue>

 
    <startPage>141</startPage>
    <endPage>147</endPage>

	 
      <doi>10.13005/bpj/592</doi>
        <publisherRecordId>418</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Probiotics for Control of Nosocomial Infections</title>

    <authors>
	 


      <author>
       <name>Ahmad Tajehmiri</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name> Saeid Rahbar</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	 


      <author>
       <name>Farhad oubari</name>

		
	<affiliationId>1</affiliationId>
      </author>
    

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.</affiliationName>
    

		
		<affiliationName affiliationId="2">Department of Microbiology, Faculty of Science, Lahijan Branch, Islamic Azad University, Lahijan, Iran</affiliationName>
    
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">Probiotics are usually defined as live microbial food ingredients beneficial to health which comprise of normal commensally bacteria as a part of the healthy human gut microflora. Different species of microorganisms such as lactic acid bacteria (<em>Bifidobacterium</em>and <em>Lactobacillus</em>spp.) or yeasts have been proposed for human use.Nosocomial infections occur worldwide and affect both developed and poor countries.The most common organisms causing nosocomialinfection in neonates include <em>Staphylococcus</em>, <em>Pseudomonas aeruginosa,Escherichiacoli</em>,<em>Klebsiella</em>, and <em>Candida</em>.There is preliminary evidence that probiotic type microorganisms may control the growth of nosocomial pathogens.The aim of this review is to consider the current evidence on the effects of probiotics for control of nosocomial infections.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol8no1/probiotics-for-control-of-nosocomial-infections/</fullTextUrl>

<keywords language="eng">

      
        <keyword>Probiotics</keyword>
      

      
        <keyword> nosocomial infections</keyword>
      

      
        <keyword> safety</keyword>
      

      
        <keyword> Infection control</keyword>
      
</keywords>
  </record>
</records>